New antibiotic made with scorpion venomBy Fernanda Duque Hernández
A new tool for the treatment of autoimmune diseases.
After 38 years of research, scientists of The National Autonomous University of Mexico (UNAM), led by Lourival Domingos Possani, have discovered two new ways to employ scorpion venom for the benefit of public health.
What the team found was a new procedure to take advantage of the peptides contained in the venom. These little proteins are used by the arachnid, not to harm others, but to protect its organism of bacteria. This makes the peptides an ideal antibiotic, even more effective than those currently in use.
This new antibiotic, currently being reviewed by The Food and Drug Administration (FDA) has shown to be greatly efficient in the laboratory when interacting with certain viruses, fungi and bacteria such as Escherichia coli.
According to Domingos, the development of this new antibiotic will improve public health whichis currently affected bythe increasing inefficiency ofantibiotics, which are often provided in large quantities, compromising the health of the patient's other organs.
The second use attributed to this poisonous substance is its effect on human lymphocytes, which could prevent the development of autoimmune diseases such as diabetes type 1, psoriasis and rheumatoid arthritis.
- “Sudan” the world’s last male white rhino dies in Africa
- Facebook tracks a scary number of details about you
- Cambridge Analytica suspends CEO amid uproar over Facebook data leak
- “Yucatan’s good public safety is attracting foreign direct investment”
- By 2021, at least 40% of Latin America's GDP will be digitized: IDC
- China’s ride-hailing giant Didi Chuxing is planning to hit Uber where it hurts
- Migrations will increase by 2050 due to climate change: Central Bank
- Warrant Sought to Inspect Cambridge Analytica
- Why Pompeo will be key to Trump’s policy towards North Korea and Iran
- United Kingdom expels 23 Russian diplomats in the wake of former spy poisoning
- Apple and Disney Place First and Second with Millennials in 2018 Brand Affinity Study
- Trump Inspects Border Wall Prototypes in California